查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600951

免疫检测市场：按产品、技术、检体、适应症和最终用户划分 - 全球预测 2025-2030 年

Immunoassay Market by Product (Analyzer, Consumables), Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay), Specimen, Indication, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年免疫检测市场估值为263亿美元，预计2024年将达282.9亿美元，预计复合年增长率为7.24%，到2030年将达429亿美元。

免疫检测是透过抗原-抗体相互作用来测量分子的存在或浓度的生化测试。它在诊断、药物分析和生化研究中发挥着重要作用。免疫测量的需求源于对准确、快速诊断解决方案日益增长的需求，特别是在临床诊断、环境监测和食品安全检测领域。免疫测量具有广泛的用途，包括疾病诊断、治疗药物监测和怀孕检测。最终用途包括医院、实验室、生技公司等。免疫检测市场受到技术进步、慢性病盛行率增加以及疾病早期检测意识增强等因素的影响。新的机会包括整合人工智慧和机器学习以增强资料解释、扩大即时检测 (POCT) 以及开发多重检测以同时检测多种分析物。创新可以集中在可携式和易于使用的设备、提高通量的自动化以及提高检测灵敏度和特异性。然而，市场成长面临挑战，例如先进检测解决方案的高成本、严格的监管标准以及检测性能可能存在的技术限制。此外，交叉反应和基质干扰等问题也会影响测定的准确性。成功克服这些挑战需要对研发进行策略性投资，以实现稳健的检测开发，并具有向诊断工具需求迅速增长的新兴经济体扩张的潜力。创新研究领域包括生物感测器、微流体和奈米技术，以提高分析性能和效率。免疫检测市场是一个竞争激烈的市场，其特点是不断创新和伙伴关係以扩大产品供应。公司必须专注于实施简化工作流程并提供强大客户支援的新技术。利用与研究机构和医疗保健提供者的合作可以推动创新和市场渗透，使您的公司处于满足不断变化的医疗保健需求的最前沿。

主要市场统计
基准年[2023] 263亿美元
预测年份 [2024] 282.9亿美元
预测年份 [2030] 429亿美元
复合年增长率（%） 7.24%

市场动态：揭示快速发展的免疫检测市场的关键市场洞察

供需的动态交互作用正在改变免疫检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病和感染疾病的增加以及早期诊断的好处
    • 扩大免疫检测在食品和饮料领域的应用
    • 多重检测免疫检测技术在药物研发的新应用
  • 市场限制因素
    • 与免疫检测相关的交叉反应问题
  • 市场机会
    • 与免疫检测相关的自动化设备和仪器数量的技术进步
    • 免疫检测在环境监测中的巨大潜力
  • 市场问题
    • 由于样品品质和试剂性能的变化而导致的测定验证问题

波特五力：驾驭免疫检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解免疫检测市场的外部影响

外部宏观环境因素在塑造免疫检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解免疫检测市场的竞争格局

对免疫检测市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵免疫检测市场供应商的绩效评估

FPNV定位矩阵是评估免疫检测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划免疫检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对免疫检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和感染疾病的增加以及早期诊断的好处
      • 免疫检测在食品和饮料行业的使用增加
      • 多重检测技术在药物研发的新应用
    • 抑制因素
      • 与免疫检测相关的交叉反应问题
    • 机会
      • 与免疫检测相关的自动化仪器和设备数量的技术进步
      • 免疫检测在环境监测中的巨大潜力
    • 任务
      • 由于样品品质和试剂性能的变化而导致的测定检验问题
  • 市场区隔分析
    • 产品：开发用于诊断感染疾病和自体免疫疾病的新型免疫检测套件
    • 技术：利用酵素结合免疫吸附测定技术治疗食物过敏和药物滥用
    • 检体：使用非侵入性采集方法进行唾液诊断的出现
    • 适应症：优化免疫检测技术以满足感染疾病整体增长的需求
    • 最终用户：急诊医学、加护病房和门诊诊所对免疫检测的需求正在增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章免疫检测市场：副产品

  • 分析仪
  • 消耗品
    • 检测试剂套件
    • 孔盘和管
    • 试剂

第七章免疫检测市场：依技术分类

  • 化学冷光免疫检测
  • 酵素免疫分析法
  • 萤光免疫分析
  • 免疫检测
  • 快速诊断测试 (RDT)/侧流免疫检测

第八章免疫检测市场（按样本）

  • 血
  • 唾液
  • 尿

第九章按适应症分類的免疫检测市场

  • 心臟病学
  • 内分泌学
  • 感染疾病
  • 肿瘤学
  • 整形外科

第 10 章免疫检测市场：依最终使用者分类

  • 血库
  • 诊断实验室
  • 食品和饮料公司
  • 医院
  • 製药公司和 CRO
  • 研究/学术机构

第十一章：美洲免疫检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太免疫检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的免疫检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Thermo Fisher 斥资 31 亿美元收购 Olink，扩大蛋白质体学业务
    • FUJIREBIO和 Sysmex 合作开发独特的免疫检测方法
    • 迈瑞同意收购德国 Diasys 诊断系统公司 75% 的股份
    • CVC基金「岛津未来创新基金」投资了开发免疫检测技术的IMMUNOSENS Co., Ltd.。
    • Fapon推出新型化学冷光免疫检测系统
    • Beckman Coulter 的 DxI 9000免疫检测分析仪具有改进的分析开发灵敏度，在 2023 年 AACC 北美首次亮相
    • 贝克曼库尔特 (Beckman Coulter) 和FUJIREBIO合作，增强患者友善血液阿兹海默症检测的可及性
    • Makati Med 成为菲律宾和东协第一家购买 Atelica VTLi 病患侧免疫检测分析仪的医院
    • QuidelOrtho Sofia 2 SARS 抗原+FIA 获得 FDA De Novo 批准
    • SGS 在普瓦捷实验室提供增强型自动化免疫检测测试
    • 西门子建立免疫检测仪器研发卓越中心
  • 战略分析和建议

公司名单

  • HU Group Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Siemens Healthineers AG
  • Tosoh Corporation
  • Merck KGaA
  • Gyros Protein Technologies AB
  • MiCo BioMed, Inc.
  • OPKO Health, Inc.
  • Promega Corporation
  • BioLegend, Inc.
  • Epitope Diagnostics Inc.
  • Dynex Technologies, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Tecan Trading AG
  • NanoEntek
  • Zoetis Inc.
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Boditech Med Inc.
  • Thermo Fisher Scientific Inc.
  • Nanomix, Inc.
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Quanterix Corporation
  • ANP Technologies, Inc.
  • Diasorin SpA
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Randox Laboratories Ltd.
  • Abbott Laboratories
  • Sysmex Corporation
  • Almac Group Limited
  • Biosurfit SA
  • Bio-Techne Corporation
  • Koninklijke Philips NV
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson, and Company
  • Agilent Technologies Inc.
  • Kamiya Biomedical Company
  • QIAGEN NV
  • Fapon Biotech Inc.
  • WAK-Chemie Medical GmbH
  • Zybio Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Autobio Diagnostics Co., Ltd.
Product Code: MRR-43127F7279BC

The Immunoassay Market was valued at USD 26.30 billion in 2023, expected to reach USD 28.29 billion in 2024, and is projected to grow at a CAGR of 7.24%, to USD 42.90 billion by 2030.

An immunoassay is a biochemical test that measures the presence or concentration of a molecule through an antigen-antibody interaction. It plays an essential role in diagnostics, pharmaceutical analysis, and biochemical research. The necessity for immunoassays arises from the growing demand for accurate and rapid diagnostic solutions, especially in clinical diagnostics, environmental monitoring, and food safety testing. Their application encompasses disease diagnosis, therapeutic drug monitoring, and pregnancy testing, among others. End-use segments include hospitals, research laboratories, and biotechnology firms. The immunoassay market is influenced by factors such as technological advancements, a rising prevalence of chronic diseases, and increasing awareness of early disease detection. Emerging opportunities include the integration of AI and machine learning for enhanced data interpretation, expanding Point-of-Care Testing (POCT), and the development of multiplex assays for simultaneously detecting multiple analytes. Innovation can focus on portable and user-friendly devices, automation to enhance throughput, and improved assay sensitivity and specificity. However, market growth faces challenges like high costs of advanced assay solutions, stringent regulatory standards, and possible technical limitations in assay performance. Additionally, issues such as cross-reactivity and matrix interference can affect assay accuracy. Successful navigation of these challenges requires strategic investment in R&D for robust assay development and potential expansion into developing economies where demand for diagnostic tools is burgeoning. Innovative areas for exploration include biosensors, microfluidics, and nanotechnology to enhance assay performance and efficiency. The immunoassay market is competitive and characterized by continuous technological innovation and partnerships to expand product offerings. Companies must focus on deploying newer technologies that streamline workflows and offer strong customer support. Leveraging collaborations with research institutes and healthcare providers can foster innovation and market penetration, placing businesses at the forefront of meeting evolving healthcare demands.

KEY MARKET STATISTICS
Base Year [2023] USD 26.30 billion
Estimated Year [2024] USD 28.29 billion
Forecast Year [2030] USD 42.90 billion
CAGR (%) 7.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoassay Market

The Immunoassay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising chronic and infectious diseases and benefits of early diagnosis
    • Growing usage of immunoassay in the food & beverage sector
    • Emerging application of multiplex detection immunoassay technique in drug development
  • Market Restraints
    • Cross-reactivity issues associated with immunoassay
  • Market Opportunities
    • Technological advancements in the number of automated instruments and equipment associated with immunoassay
    • High potential of immunoassay in environment monitoring
  • Market Challenges
    • Issues with assay validation due to variations in sample quality and reagent performance

Porter's Five Forces: A Strategic Tool for Navigating the Immunoassay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoassay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoassay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoassay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoassay Market

A detailed market share analysis in the Immunoassay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoassay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoassay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoassay Market

A strategic analysis of the Immunoassay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoassay Market, highlighting leading vendors and their innovative profiles. These include H.U. Group Holdings Inc., Charles River Laboratories International, Inc., Siemens Healthineers AG, Tosoh Corporation, Merck KGaA, Gyros Protein Technologies AB, MiCo BioMed, Inc., OPKO Health, Inc., Promega Corporation, BioLegend, Inc., Epitope Diagnostics Inc., Dynex Technologies, Inc., Danaher Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Tecan Trading AG, NanoEntek, Zoetis Inc., Shenzhen Micropoint Biotechnologies Co., Ltd., Boditech Med Inc., Thermo Fisher Scientific Inc., Nanomix, Inc., bioMerieux S.A., QuidelOrtho Corporation, Quanterix Corporation, ANP Technologies, Inc., Diasorin S.p.A., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Randox Laboratories Ltd., Abbott Laboratories, Sysmex Corporation, Almac Group Limited, Biosurfit SA, Bio-Techne Corporation, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Becton, Dickinson, and Company, Agilent Technologies Inc., Kamiya Biomedical Company, QIAGEN N.V., Fapon Biotech Inc., WAK-Chemie Medical GmbH, Zybio Inc., J. Mitra & Co. Pvt. Ltd., and Autobio Diagnostics Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Immunoassay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analyzer and Consumables. The Consumables is further studied across Assay Kits, Microwell Plates & Tubes, and Reagents.
  • Based on Technology, market is studied across Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay, Radioimmunoassay, and Rapid Diagnostic Tests (RDTs)/Lateral Flow Immunoassay.
  • Based on Specimen, market is studied across Blood, Saliva, and Urine.
  • Based on Indication, market is studied across Cardiology, Endocrinology, Infectious Disease, Oncology, and Orthopedics.
  • Based on End User, market is studied across Blood Banks, Diagnostics Laboratories, Food & Beverage Companies, Hospitals, Pharmaceutical Companies & CROs, and Research & Academic Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising chronic and infectious diseases and benefits of early diagnosis
      • 5.1.1.2. Growing usage of immunoassay in the food & beverage sector
      • 5.1.1.3. Emerging application of multiplex detection immunoassay technique in drug development
    • 5.1.2. Restraints
      • 5.1.2.1. Cross-reactivity issues associated with immunoassay
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the number of automated instruments and equipment associated with immunoassay
      • 5.1.3.2. High potential of immunoassay in environment monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Issues with assay validation due to variations in sample quality and reagent performance
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Development of novel immunoassay kits for diagnostics of infectious and autoimmune diseases
    • 5.2.2. Technology: Utilization of enzyme-linked immunosorbent assay technology for food allergies and drugs of abuse treatment
    • 5.2.3. Specimen: Emergence of saliva diagnostics due to its non-invasive collection methods
    • 5.2.4. Indication: Optimization within immunoassay technologies to cater growing need across infectious disease
    • 5.2.5. End User: Rising demand for immunoassay across emergency care, intensive care units, and outpatient clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoassay Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzer
  • 6.3. Consumables
    • 6.3.1. Assay Kits
    • 6.3.2. Microwell Plates & Tubes
    • 6.3.3. Reagents

7. Immunoassay Market, by Technology

  • 7.1. Introduction
  • 7.2. Chemiluminescence Immunoassay
  • 7.3. Enzyme-linked Immunosorbent Assay
  • 7.4. Fluoroimmunoassay
  • 7.5. Radioimmunoassay
  • 7.6. Rapid Diagnostic Tests (RDTs)/Lateral Flow Immunoassay

8. Immunoassay Market, by Specimen

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Saliva
  • 8.4. Urine

9. Immunoassay Market, by Indication

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Endocrinology
  • 9.4. Infectious Disease
  • 9.5. Oncology
  • 9.6. Orthopedics

10. Immunoassay Market, by End User

  • 10.1. Introduction
  • 10.2. Blood Banks
  • 10.3. Diagnostics Laboratories
  • 10.4. Food & Beverage Companies
  • 10.5. Hospitals
  • 10.6. Pharmaceutical Companies & CROs
  • 10.7. Research & Academic Laboratories

11. Americas Immunoassay Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Immunoassay Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Immunoassay Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Thermo Fisher to Acquire Olink for USD 3.1 billion, Expanding Proteomics Presence
    • 14.3.2. Fujirebio and Sysmex to Collaborate On Development of Unique Immunoassays
    • 14.3.3. Mindray Has Agreed to Acquire 75% Stake in Germany-Based DiaSys Diagnostic Systems GmbH
    • 14.3.4. CVC Fund "Shimadzu Future Innovation Fund" has Invested in IMMUNOSENS Co., Ltd., Developing Immunoassay Technology.
    • 14.3.5. Fapon Rolls Out New Chemiluminescence Immunoassay System
    • 14.3.6. Beckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC
    • 14.3.7. Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer's Disease Test
    • 14.3.8. MakatiMed First PH and ASEAN Hospital to Acquire Atellica VTLi Patient-Side Immunoassay Analyzer
    • 14.3.9. QuidelOrtho Receives De Novo FDA Authorization for Sofia 2 SARS Antigen+ FIA
    • 14.3.10. SGS Offers Enhanced Automated Immunoassay Testing at Poitiers Laboratory
    • 14.3.11. Siemens launches Centre of Excellence for Immunoassay Instrument R&D
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. H.U. Group Holdings Inc.
  • 2. Charles River Laboratories International, Inc.
  • 3. Siemens Healthineers AG
  • 4. Tosoh Corporation
  • 5. Merck KGaA
  • 6. Gyros Protein Technologies AB
  • 7. MiCo BioMed, Inc.
  • 8. OPKO Health, Inc.
  • 9. Promega Corporation
  • 10. BioLegend, Inc.
  • 11. Epitope Diagnostics Inc.
  • 12. Dynex Technologies, Inc.
  • 13. Danaher Corporation
  • 14. PerkinElmer, Inc.
  • 15. Bio-Rad Laboratories, Inc.
  • 16. Tecan Trading AG
  • 17. NanoEntek
  • 18. Zoetis Inc.
  • 19. Shenzhen Micropoint Biotechnologies Co., Ltd.
  • 20. Boditech Med Inc.
  • 21. Thermo Fisher Scientific Inc.
  • 22. Nanomix, Inc.
  • 23. bioMerieux S.A.
  • 24. QuidelOrtho Corporation
  • 25. Quanterix Corporation
  • 26. ANP Technologies, Inc.
  • 27. Diasorin S.p.A.
  • 28. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 29. Randox Laboratories Ltd.
  • 30. Abbott Laboratories
  • 31. Sysmex Corporation
  • 32. Almac Group Limited
  • 33. Biosurfit SA
  • 34. Bio-Techne Corporation
  • 35. Koninklijke Philips N.V.
  • 36. F. Hoffmann-La Roche Ltd.
  • 37. Becton, Dickinson, and Company
  • 38. Agilent Technologies Inc.
  • 39. Kamiya Biomedical Company
  • 40. QIAGEN N.V.
  • 41. Fapon Biotech Inc.
  • 42. WAK-Chemie Medical GmbH
  • 43. Zybio Inc.
  • 44. J. Mitra & Co. Pvt. Ltd.
  • 45. Autobio Diagnostics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. IMMUNOASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROWELL PLATES & TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS)/LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IMMUNOASSAY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL IMMUNOASSAY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL COMPANIES & CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2023